{"id":385139,"date":"2024-10-30T00:01:00","date_gmt":"2024-10-29T23:01:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=385139"},"modified":"2024-10-30T21:03:53","modified_gmt":"2024-10-30T20:03:53","slug":"fibrofolliculomas-as-indicator-lesions","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/fibrofolliculomas-as-indicator-lesions\/","title":{"rendered":"Fibrofolliculomas as indicator lesions"},"content":{"rendered":"\n<p><strong>The vast majority of patients affected by this rare hereditary tumor syndrome develop numerous fibrofolliculomas in middle age, particularly on the face and upper body.\nGenetic testing is required to confirm the diagnosis of Birt-Hogg-Dub\u00e9 syndrome.\nAffected patients should be referred to a lung and kidney specialist and to genetic counseling.    <\/strong><\/p>\n\n<!--more-->\n\n<p>The cutaneous features of the disease and the autosomal dominant inheritance mechanism were described in 1977 by three Canadian physicians (Birt, Hogg, Dub\u00e9) [1].\nSubsequently, numerous case reports showed that there could be an association with renal tumors, pulmonary cysts and the occurrence of spontaneous pneumothorax.\nThe prevalence of Birt-Hogg-Dub\u00e9 syndrome (BHD) is estimated at 1:200,000, but the exact incidence is unknown [2].\nThe cause of BHD is a mutation of the FLCN gene at gene locus 17p11.2.\nThe gene codes for folliculin.\nThe exact function of this protein is currently still the subject of basic research.\nHowever, it is assumed that FLCN plays a role as a tumor suppressor protein.\nThe diagnosis of BHD is confirmed by molecular biological detection of the gene mutation.\nThe distribution and morphology of the cysts on imaging can be indicative.\nTypically, the lung cysts have thin walls and are located in the basal, subpleural and paramediastinal sections of the lung.           <\/p>\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><a href=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2024\/08\/abb1-DP4_s42.jpg\"><img fetchpriority=\"high\" decoding=\"async\" width=\"926\" height=\"778\" src=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2024\/08\/abb1-DP4_s42.jpg\" alt=\"\" class=\"wp-image-384920\" style=\"width:300px\" srcset=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2024\/08\/abb1-DP4_s42.jpg 926w, https:\/\/medizinonline.com\/wp-content\/uploads\/2024\/08\/abb1-DP4_s42-800x672.jpg 800w\" sizes=\"(max-width: 926px) 100vw, 926px\" \/><\/a><\/figure>\n<\/div>\n<h2 id=\"cutaneous-and-extracutaneous-manifestations\" class=\"wp-block-heading\">Cutaneous and extracutaneous manifestations  <\/h2>\n\n<p>The characteristic skin changes in BHD are fibrofolliculomas.\nThey appear as multiple, 2-5 mm large, whitish-yellowish efflorescences that do not cause itching [1].\nThe exact clinical picture is variable &#8211; the tumors can appear as relatively inconspicuous plaques or as larger papules with a horny plug that resemble comedones or small epidermoid cysts.\nHistologically, they are circumscribed fibroblast nests with an accumulation of collagen around deformed hair follicles, from which basaloid cells extend into the surrounding tissue.\nTypically, the efflorescences usually occur on the face, neck and upper body.\nThe number of tumors and their size increase over time.\nOther common skin findings are angiofibromas and acrochordons.      <\/p>\n\n<p>The possible extracutaneous manifestations of BHD are manifold [1]:  <\/p>\n\n<ul class=\"wp-block-list\">\n<li><em>Urogenital tract:<\/em> greatly increased risk of kidney tumors of varying dignity (benign oncocytomas, renal cell carcinomas and mixed tumors)<\/li>\n\n\n\n<li><em>Gastrointestinal tract:<\/em> multiple colonic polyps that can degenerate into colorectal carcinomas<\/li>\n\n\n\n<li><em>Respiratory tract:<\/em> pulmonary cysts, bronchiectasis and emphysema blisters, pulmonary hamartomas; the risk of pneumothorax in BHD is about 50 times higher<\/li>\n\n\n\n<li><em>Other:<\/em> Changes to the eye (retinopathies, glaucoma) and the thyroid gland (thyroid carcinoma, hypothyroidism) can also occur.<\/li>\n<\/ul>\n\n<h3 id=\"case-study\" class=\"wp-block-heading\">Case study <\/h3>\n\n<p>An issue of the <em>Aesthetic Surgery Journal Open Forum<\/em> published last year described the case of a 53-year-old Caucasian female patient who complained of uneven skin with small growths on her face and neck.\nThese had previously been treated as ordinary warts or skin papillomas [3].\nThere were no clinical or laboratory signs of autoimmunity or immunodeficiency.\nThe patient stated that the skin problems had started at the age of 25 and since then she had tried various treatments such as laser therapy, skin peels, cryotherapy and topical agents.   <\/p>\n\n<p><strong>Clinical appearance: <\/strong>Her face was covered with blotchy, hypopigmented areas, which may have had something to do with the various treatments to remove the skin growths (supposed warts).\nThe skin of the face, neck and abdomen was covered with numerous skin-colored papules 2-8 mm in diameter, which occasionally itched.\nThe appearance was consistent with the fibrofolliculomas described by Tong et al.\ndescribed fibrofolliculomas [4].\nIn addition, several acrochordons were observed on the patient&#8217;s neck and upper chest [5].\nThe lumpy, uneven appearance, especially on the neck, was perceived as stigmatizing by the patient.       <\/p>\n\n<p><strong>Medical history: <\/strong>The anamnestic clarification revealed four spontaneous pneumothoraces at a young age and a pleurectomy at the age of 30.\nShe had also had several colon polyps removed in the past.\nIn addition, it turned out that the patient suffered from Fuchs endothelial dystrophy, which affected both eyes.\nAt the age of 23, she had a benign cyst on her scalp surgically removed and recently a digital mucosal cyst on her left hand.\nShe also reports that she was diagnosed with polycystic ovary syndrome, to which she attributes her fertility problems of seven years.\nThe patient also stated that there was no known BHD in her family.     <\/p>\n\n<p><strong>Diagnostic procedure: <\/strong>A small, 3 mm, flesh-colored, dome-shaped papule was surgically removed from the neck and sent to pathology.\nAccording to pathologic evaluation, it was a fibrofolliculoma, which appeared as a cystically dilated central follicle surrounded by loose connective tissue.\nIn this case, the cystic cavity was filled with keratin deposits and lined by keratinizing squamous epithelium resembling normal epidermis.\nThe patient underwent a whole-body computed tomography scan, which revealed benign cysts in both lungs and the right kidney.\nA clinical diagnosis of BHD was made and the patient was asked to undergo genetic testing for mutations in the FLCN gene 17p 11.2.\nThe genetic test was positive, confirming the diagnosis of BHD.\nThe patient was also referred to a lung and kidney specialist and to genetic counseling.      <\/p>\n\n<p><strong>Treatment:<\/strong> An electrosurgical procedure was recommended to remove the aesthetically disturbing fibrofolliculomas and papillomas in the neck and abdomen area, while microneedling with the application of topical exosomes was used for the sagging skin and irregular pigmentation.\nThe aim was to use this combination therapy to treat the uneven skin texture caused by ageing processes and previous treatments for fibrofolliculomas.\nIn addition, the combination therapy aimed to remodel the superficial dermal tissue.\nThe protocol comprised three treatment episodes at intervals of approximately one month:     <\/p>\n\n<ul class=\"wp-block-list\">\n<li>First, ten series of microneedling <em>(Dermapen<sup>4th<\/sup> Generation; Derma Pen, LLC; Terrey Hills, Australia) <\/em>were performed in each area (face, neck, chest) at a depth of 0.5 to 1.0 mm in a horizontal, vertical and oblique direction.  <\/li>\n\n\n\n<li>During and after the microneedling application, topical exosomes <em>(Exocode Radiance; ExoCoBio, Seoul, South Korea) <\/em>were gently massaged into the skin <em>. <\/em> <\/li>\n<\/ul>\n\n<p>The patient tolerated the treatment well and was satisfied with the results so far.\nThe degree of depigmentation and the presence of papilomas have improved significantly.\nVisible improvements were seen more quickly on the face than on the neck and d\u00e9collet\u00e9 [6].\nThe patient was recommended to continue the treatments for another three sessions, especially in the neck and d\u00e9collet\u00e9 area.\nTheodorakopoulou et al.\nstate that although recurrent fibrofolliculomas are harmless and easily treatable, it is important to initiate appropriate diagnostic investigations if BHD is suspected.     <\/p>\n\n<figure class=\"wp-block-table\"><table class=\"has-background has-fixed-layout\" style=\"background-color:#0792e333\"><tbody><tr><td><strong>No causal treatment is currently available<\/strong><br\/>As the genetic defect cannot currently (as of 2024) be treated causally, treatment is exclusively symptomatic [1].\nThe fibrofolliculomas can be removed dermatosurgically (e.g. by laser ablation or curettage).\nPatients are regularly examined for renal tumors using imaging techniques (sonography, MRI).\nIf a tumor occurs, a partial or total nephrectomy may be necessary.\nIf the lungs are affected, this is not usually associated with a progressive reduction in lung function and respiratory insufficiency.    <\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p><strong>Conclusion for practice  <\/strong><\/p>\n\n<ul class=\"wp-block-list\">\n<li>In &gt;90% of patients with Birt-Hogg-Dub\u00e9 syndrome (BHD), numerous fibrofolliculomas usually manifest between the ages of 20 and 40.  <\/li>\n\n\n\n<li>Targeted tumor screening is crucial for the prognosis of BHD, as there is a lifetime risk of 12-34% for benign and malignant renal tumors.  <\/li>\n\n\n\n<li>Early diagnosis and long-term care of families with BHD require interdisciplinary cooperation.<\/li>\n\n\n\n<li>In cases of clinical suspicion, genetic testing for a mutation in the FLCN gene at gene locus 17p11.2 provides certainty.\nBHD syndrome is inherited in an autosomal dominant manner. <\/li>\n<\/ul>\n\n<p><\/p>\n\n<p>Literature:  <\/p>\n\n<ol class=\"wp-block-list\">\n<li>&#8220;Birt-Hogg-Dub\u00e9 syndrome&#8221;, <a href=\"https:\/\/flexikon.doccheck.com\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/flexikon.doccheck.com,<\/a>(last accessed 12.08.2024).<\/li>\n\n\n\n<li>&#8220;Birt-Hogg-Dub\u00e9 syndrome&#8221;, <a href=\"http:\/\/www.orpha.net\/de\/disease\/detail\/122\" target=\"_blank\" rel=\"noopener\">www.orpha.net\/de\/disease\/detail\/122,<\/a>(last accessed 12.08.2024).<\/li>\n\n\n\n<li>Theodorakopoulou E, et al.: Birt-Hogg-Dub\u00e9 Syndrome: A Rare Genodermatosis Presenting as Skin Papillomas. Aesthet Surg J Open Forum. 2023 Jul 12;5: ojad064. doi: 10.1093\/asjof\/ojad064.<\/li>\n\n\n\n<li>Tong Y, et al: Birt-Hogg-Dub\u00e9 syndrome: a review of dermatological manifestations and other symptoms. Am J Clin Dermatol 2018; 19: 87-101. <\/li>\n\n\n\n<li>Schmidt LS, Linehan WM: FLCN: the causative gene for Birt-Hogg-Dub\u00e9 syndrome. Gene 2018; 640: 28\u201342.  <\/li>\n\n\n\n<li>Ablon G: Safety and effectiveness of an automated microneedling device in improving the signs of aging skin. J Clin Aesthetic Dermatol 2018; 11(8): 29\u201334.  <\/li>\n\n\n\n<li>Steinlein OK, et al.: Birt-Hogg-Dub\u00e9-Syndrom: ein zu selten diagnostiziertes erbliches Tumorsyndrom. J Dtsch Dermatol Ges 2018; 16(3): 278\u2013284.<\/li>\n<\/ol>\n\n<p class=\"has-small-font-size\"><em>DERMATOLOGIE PRAXIS 2024; 34(4): 42\u201343<br\/>InFo ONKOLOGIE  H\u00c4MATOLOGIE 2024; 12(4): 26\u201327<\/em><\/p>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The vast majority of patients affected by this rare hereditary tumor syndrome develop numerous fibrofolliculomas in middle age, particularly on the face and upper body. Genetic testing is required to&hellip;<\/p>\n","protected":false},"author":7,"featured_media":385141,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Birt-Hogg-Dub\u00e9 syndrome  ","footnotes":""},"category":[11548,11520,11340,11508,11391,11297,11396,11400,11413,11370,11423,11455,11490],"tags":[78227,78228,78230,78231,44961,78229],"powerkit_post_featured":[],"class_list":["post-385139","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-cases-en","category-dermatology-and-venereology","category-education","category-gastroenterology-and-hepatology","category-general-internal-medicine","category-genetics","category-gynecology","category-nephrology","category-oncology","category-ophthalmology","category-pneumology","category-urology","tag-birt-hogg-dube-en","tag-birt-hogg-dube-syndrome","tag-fibrofolliculomas","tag-indicator-lesions","tag-rare-disease-en","tag-tumor-syndrome","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-19 17:59:45","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":385133,"slug":"fibrofolliculomes-comme-lesions-indicatrices","post_title":"Fibrofolliculomes comme l\u00e9sions indicatrices","href":"https:\/\/medizinonline.com\/fr\/fibrofolliculomes-comme-lesions-indicatrices\/"},"it_IT":{"locale":"it_IT","id":385126,"slug":"fibrofolliculomi-come-lesioni-indicatrici","post_title":"Fibrofolliculomi come lesioni indicatrici","href":"https:\/\/medizinonline.com\/it\/fibrofolliculomi-come-lesioni-indicatrici\/"},"pt_PT":{"locale":"pt_PT","id":385120,"slug":"fibrofoliculomas-como-lesoes-indicadoras","post_title":"Fibrofoliculomas como les\u00f5es indicadoras","href":"https:\/\/medizinonline.com\/pt-pt\/fibrofoliculomas-como-lesoes-indicadoras\/"},"es_ES":{"locale":"es_ES","id":385114,"slug":"fibrofoliculomas-como-lesiones-indicadoras","post_title":"Fibrofoliculomas como lesiones indicadoras","href":"https:\/\/medizinonline.com\/es\/fibrofoliculomas-como-lesiones-indicadoras\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/385139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=385139"}],"version-history":[{"count":3,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/385139\/revisions"}],"predecessor-version":[{"id":389400,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/385139\/revisions\/389400"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/385141"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=385139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=385139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=385139"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=385139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}